Robert K. Coughlin
President & CEO
MassBio Abbie Celniker
Partner, Third Rock Ventures
Interim CEO, Goldfinch Bio Steve Woit
Director
BioPharma Executive Council Sarah MacDonald
Executive Vice President
MassBio David Lawrence Lucchino
Co-founder, President and CEO
Frequency Therapeutics Kate Bingham
Managing Partner
SV Life Sciences Terry McGuire
Founding Partner
Polaris Partners Mike O’Hara
Partner
Deloitte Christoph Westphal
CEO
Flex Pharma Annalisa Jenkins
CEO
Dimension Therapeutics Steve Kafka
President
Foundation Medicine Travis McCready
President & CEO
Massachusetts Life Sciences Center William McDermott
Partner
McDermott, Quilty & Miller LLP Chris Garabedian
Chairman
Xontogeny LLC Christopher de Souza
Director
Broadview Ventures Geoff MacKay
President & CEO
AvroBio James Hoyes
Executive Partner
RxC International Robert Gottlieb
Principal
RMG Associates Melissa Bradford Klug
Chief Business Officer
Keryx Antony Loebel
Executive Vice President & Chief Medical Officer
Sunovion Pharmaceuticals Inc. Alice Pomponio
Vice President, Corporate Affairs
Radius Health Rick Russell
President & CEO
Stallergenes Greer Inc. Marina Bozilenko
Managing Director
William Blair Mark Perrin
CEO & Chairman
InVivo Therapeutics Corporation Eileen Coveney
Managing Director
L.E.K. Consulting Arthur Hiller
CEO
Antyllus Therapeutics Nancy Lurker
President & CEO
pSivida Bob Linke
President & CEO
Embera NeuroTherapeutics Ailis Tweed-Kent
CEO
Cocoon Biotech Patrice Milos
CEO
Medley Genomics Jonathan Lewis
CEO
Samus Therapeutics David Moller
VP, BD, Emerging Technology & Innovation
Eli Lilly & Company Ed Mascioli
CEO
Karos Pharmaceuticals Bram Goorden
VP Global Head
Nestle Health Science Doug Kahn
Chairman and CEO
TetraGenetics Laurie Halloran
CEO
Halloran Consulting Group Jim Jensen
CEO
CytoSite Biopharma Carolyn Green
Director, Strategic Investments
Pfizer Deborah Dunsire
Principal
Southern Cross Biotech Consulting Patrick Tricoli
CEO
Nanobiotix Bruce Rychlik
Managing Partner
Park Square Executive Search Erik Lundh
Managing Partner
Park Square Executive Search Tara Schutz
Vice President
Morgan Stanley John Mendlein
CEO
ATyr Kathy Williams
Head of Life Sciences
Sunstein, LLP Chandra Ramanathan
VP and Head of East Coast Innovation Center
Bayer, U.S. Vin Milano
CEO
Idera Pharmaceuticals Marianne De Backer
VP, Johnson & Johnson Innovation
Janssen Business Development Sue Dillon
Global Therapeutic Area Head, Immunology
Johnson & Johnson, Janssen Pharmaceuticals William Newell
CEO
Sutro Biopharma Steve Tregay
CEO
FORMA Therapeutics Vivek Ramaswamy
CEO
Roivant Sciences and Axovant Sciences Wendye Robbins
CEO
Blade Therapeutics Elizabeth Franzmann
Chief Scientific Officer
Vigilant Biosciences Filipe Gaspar
VP R&D
Hovione John Furey
COO
Spark Therapeutics Bonnie Fendrock
CEO
Cyta Therapeutics Glen Giovannetti
Global Biotechnology Leader
EY Rob Perez
Managing Director, Vineyard Sound Advisors
Founder and President, Life Science Cares | Cissy Young
Partner
Russell Reynolds Jodie Morrison
CEO and President
Tokai Pharmaceuticals Susan Windham-Bannister
President & CEO
BioMedical Growth Strategies David Meeker
EVP, General Manager
Sanofi Genzyme Michael J. Pellini
Chairman
Foundation Medicine Phillip Sharp
Institute Professor
MIT Ann Stanesa
President
Ten Bridge Communications Lisa Olson
Vice President, Immunology Research & ABC Site Head
AbbVie Edward Kaye
President, CEO, and Chief Medical Officer
Sarepta Therapeutics Ivana Magovčević-Liebisch
SVP, Head of Corporate Development
Teva Pharmaceuticals Suzanne Bruhn
Director
Pliant Therapeutics & Raptor Pharmaceutical Robert Urban
Global Head
Johnson & Johnson Innovation Scott Gillis
President
Pericor Science, Inc. Michael D. Ehlers
EVP, Research & Development
Biogen Geoff Cox
Principal
Beacon Street Advisors Lawrence S. Wittenberg
Senior Partner
Goodwin Procter LLP Kumar Srinivasan
VP, Scientific Partnering & Alliances, IMED Biotech Unit
AstraZeneca Pharmaceuticals Kathleen W. Tregoning
SVP, Corporate Affairs
Biogen Mark R. Bamforth
President and CEO
Brammer Bio Robert Ward
CEO
Radius Health Tina Caporale
Managing Director, Audit
Deloitte Andrea F. Rabney
President and Chief Executive Officer
Argot Partners Christopher T. Walsh
Professor
Harvard Medical School Marian Nakada
VP, Venture Investments
Johnson & Johnson Innovation Mike Rice
Founding Partner
LifeSci Advisors Adam Gridley
CEO
Histogenics Bob Carpenter
Director
Hydra Biosciences Alexis Wallace
CEO
Thrombolytic Science Deniz Kural
CEO
Seven Bridges Genomics Praveen Tipirneni
CEO
Morphic Therapeutic Paula Soteropoulos
CEO
Akcea Therapeutics Philippe Lopes-Fernandes
SVP, Head of Global Licensing & Business Development
Merck KGaA/Merck Serono Jennifer Wheler
Senior Medical Director
Novartis Sheila DeWitt
President & CEO
DeuteRx Lisa McKerracher
CEO
BioAxone BioSciences Michael Schopperle
CEO
CureMeta Leslie Williams
CEO
ImmusanT Rosanna Kapeller
Chief Scientific Officer
Nimbus Therapeutics Art Krieg
CEO
Checkmate Pharmaceuticals Anne Deconinck
Executive Director
MIT Koch Institute Guy Villax
CEO
Hovione Mary Thistle
COO
Dimension Therapeutics Kathy Bowdish
Head and VP Global R&D
Sanofi Sunrise Jody Rose
Executive Director
New England Venture Capital Association Ron Renaud
CEO
RaNa Therapeutics Joanna Horobin
SVP, Chief Medical Officer
Idera Pharmaceuticals Cat Oyler
VP Strategy and External Innovation
Johnson & Johnson, Janssen Research and Development Marion Dorsch
Chief Scientific Officer
Blueprint Medicines Jay Luly
CEO
Enanta Pharmaceuticals Lynn Seeley
CEO
Myovant Sciences Alvin Shih
CEO
Enzyvant Sciences Arielle Jackson
Portfolio Director
Boston Biotech Conferences John Tagliamonte
Advisor Board Member
WntRx Pharmaceuticals Jeff Marrazzo
CEO
Spark Therapeutics Lisa Dalton
Head of Human Resources
Spark Therapeutics Ana Maiques
CEO
Neuroelectrics Javier Barrientos
Senior Director, Global Diversity and Inclusion
Biogen Karl Simpson
Owner & CEO
Liftstream |
It is unbelievable that in the XXI century we are struggling to achieve “gender diversity.” If many companies and institutions still do not understand the need to have women having the same rights in all sense as men, then those institutions from many points of view are still living in the XIV century or earlier. If some people working with scientists oppose the equal rights of both women and man, then they are in the wrong field. Indeed, history have shown us that many women working under disadvantageous conditions have excel in science and contribute to its progress. Hopefully, in a few years more, this need to ask for gender diversity will be just a footnote in the history of science.